Company / Income Tax
Xenon Pharmaceuticals Inc. Income Tax History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$1.0M
FY2025
5-year range
-$4.1M / $1.0M
FY2021-FY2025
Trend
+124.8%
vs FY2024
Sector context
#73 of 204
Health Care
What the data says
At $1M, Xenon Pharmaceuticals Inc.'s income tax ranks #132 of 204 in the Health Care sector. Income Tax returned to growth in FY2025 after 2 years of decline, reaching $1M.
Based on SEC 10-K filings.
$1M in FY2025 with a 3-year CAGR of +105.0%.
Increased from -$292,000 to $1M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +105.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#132 of 204 in Health CareTop 64% of 204This company $1.0M Sector average $118.7M
▼
-99.1% below sector average
Key checks
Key Insights
- 3-year CAGR of +105.0%, indicating consistent growth.
- In FY2025, income tax increased 124.8% year-over-year.
- Ranks #73 out of 204 companies in the Health Care sector.
- Lowest income tax in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.0M | +124.8% |
| FY2024 | -$4.1M | -1300.3% |
| FY2023 | -$292.0K | -347.5% |
| FY2022 | $118.0K | +2066.7% |
| FY2021 | -$6.0K | +97.7% |
| FY2020 | -$257.0K | -1017.4% |
| FY2019 | -$23.0K | +4.2% |
| FY2018 | -$24.0K | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026